Evidence map›Paper›PMID 37171488›Full record

ArticleEuropean radiology2023

Spectrum of neuroradiological manifestations in primary hemophagocytic lymphohistiocytosis: a comparative study of EBV-induced versus non-EBV-induced forms in 75 genetically confirmed pediatric cases.

Hélène Charpentier, Charles-Joris Roux, Pauline Leroux, Coralie Briand, Raphaël Levy, Volodia Dangouloff-Ros, Isabelle Desguerre, Bénédicte Neven, Despina Moshous, Nathalie Boddaert

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hélène CharpentierDepartment of Radiology, University Hospital Besançon, 25000, Besançon, France. helene.charpentier@univ-fcomte.fr.ORCID http://orcid.org/0000-0001-6219-8604
Charles-Joris RouxDepartment of Pediatric Radiology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Pauline LerouxDepartment of Pediatrics, Sud Francilien Hospital, 91100, Corbeil-Essonnes, France.
Coralie BriandDepartment of Pediatrics, Jean-Verdier Hospital, 93140, Bondy, France.
Raphaël LevyDepartment of Pediatric Radiology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Volodia Dangouloff-RosDepartment of Pediatric Radiology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Isabelle DesguerreDepartment of Neurology and Metabolism, Necker-Enfants Malades Hospital, 75015, Paris, France.
Bénédicte NevenDepartment of Pediatric Immunology, Hematology, and Rheumatology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Despina MoshousDepartment of Pediatric Immunology, Hematology, and Rheumatology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Nathalie BoddaertDepartment of Pediatric Radiology, Necker-Enfants Malades Hospital, 75015, Paris, France.
Hôpital Necker-Enfants Malades · FRCentre Hospitalier Sud Francilien · FRCentre Hospitalier Universitaire de Besançon · FRHôpital Jean-Verdier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition affecting young children. It is potentially triggered by Epstein-Barr virus (EBV). This study describes the neuroradiological features observed in 75 children with genetically confirmed primary HLH, comparing EBV-induced with non-EBV-induced HLH forms.

methodsBrain MRIs between 2007 and 2021 from 75 children with HLH according to the 2004 Histiocyte Society criteria and with a confirmed HLH-related mutation, were retrospectively reviewed by two pediatric neuroradiologists blinded to EBV status and to mutation status. At diagnosis, 17 children with EBV viremia above a threshold of 1000 copies/mL were included in the EBV-induced HLH group. The remaining 58 patients were included in the non-EBV-induced HLH group.

resultsOf the 75 children initially included, 21 had abnormal MRI (21/75 (28%); 9/17 in the EBV-induced HLH group and 12/58 in the non-EBV-induced HLH group). All patients with abnormal MRI had neurological symptoms. Abnormal MRIs showed white matter lesions; the posterior fossa was affected in all but one case. There was no significant difference between groups regarding the localization or morphology of white matter lesions. The striatum was more frequently affected in the EBV-induced HLH group (8/9 (89%) versus 1/12 (8%), p = 0.00037). All lesions, whether in the white matter or in the basal ganglia, presented increased ADC values on diffusion weighted imaging (DWI).

conclusionIn this study of 75 children with genetically confirmed HLH, only children with neurological signs had abnormal brain MRI. Bilateral striatum involvement suggested an EBV-induced form of HLH. KEY POINTS: • In children with genetically proven HLH, only those with neurological signs did have brain abnormalities at MRI. • All patients with abnormal brain MRI had multiple white matter lesions with increased ADC values, including in the posterior fossa in almost all cases. • Basal ganglia and in particular the striatum were bilaterally and symmetrically affected in almost all EBV-induced HLH patients, in contrast to the non-EBV-induced HLH patients.

Indexed as

Epstein-Barr Virus InfectionsLymphohistiocytosis, HemophagocyticChildChild, PreschoolCorpus StriatumHerpesvirus 4, HumanHumansRetrospective StudiesBasal gangliaEpstein-Barr virus infectionsHemophagocytic lymphohistiocytosisMagnetic resonance imagingMutation

Identifiers

PMID37171488
OpenAlexW4376226660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.